Download
10.1186_s40463-020-00467-w.pdf 1,18MB
WeightNameValue
1000 Titel
  • The role of brachytherapy for margin control in oral tongue squamous cell carcinoma
1000 Autor/in
  1. Ianovski, Ilia |
  2. Mlynarek, Alex M. |
  3. Black, Martin J. |
  4. Bahoric, Boris |
  5. Sultanem, Khalil |
  6. Hier, Michael |
1000 Verlag
  • SAGE Publications
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-01-01
1000 Erschienen in
1000 Quellenangabe
  • 49(1):74
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s40463-020-00467-w |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556952/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • <jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>The aim of this study is to assess the feasibility and effectiveness of using peri-operative brachytherapy (BRTx) for positive/narrow margins present post primary surgical resection of oral tongue squamous cell carcinoma (OTSCC).</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>Prospective single-centre study of patients with OTSCC (T1–3, N0–3, M0) treated with resection of primary tumour ± regional nodal resection and intra-operative insertion of BRTx catheters. BRTx was administered twice daily at 40.8Gy/12Fr for ‘Positive’ (≤2 mm) margins, at 34Gy/10Fr for ‘Narrow’ (2.1-5 mm) margins, and not given for ‘Clear’ (&gt; 5 mm) margins over the course of 5–6 days, 3–5 days post operatively.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Out of 55 patients recruited 41 patients (74.6%) were treated with BRTx, as 12 patients had clear margins and 2 patients had unfavourable tumour anatomy for catheter insertion. EBRTx was avoided in 64.3% of patients. Overall Survival (OS) at 3 and 5 years was 75.6 and 59.1% respectively, while Disease Specific Survival (DSS) was 82.3 and 68.6% at 3 and 5 years respectively. Recurrence and survival outcomes were not associated with margin status or the use of or specific dose of BRTx on Cox regression analysis. Acute and late toxicity secondary to BRTx was minimal.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>The use of BRTx after primary OTSCC resection with positive/narrow margins ± EBRTx to the neck ± CTx achieves outcomes comparable to traditional treatment of surgery followed by re-resection or EBRTx ± CTx. Morbidity associated with oral cavity EBRTx or secondary resection and reconstruction is thus avoided. Both acute and late toxicity rates are low and compare favourably with other BRTx OTSCC studies.</jats:p></jats:sec><jats:sec><jats:title>Trial registration</jats:title><jats:p>Retrospectively registered.<jats:ext-link xmlns:xlink='http://www.w3.org/1999/xlink' ext-link-type='uri' xlink:href='https://www.mcgill.ca/rcr-rcn/files/rcr-rcn/2017.06.05_rcn_hn.pdf'>https://www.mcgill.ca/rcr-rcn/files/rcr-rcn/2017.06.05_rcn_hn.pdf</jats:ext-link>.</jats:p></jats:sec><jats:sec><jats:title>Level of evidence</jats:title><jats:p>4</jats:p></jats:sec><jats:sec><jats:title>Graphical abstract</jats:title></jats:sec>
1000 Sacherschließung
lokal Carcinoma, Squamous Cell/mortality [MeSH]
lokal Brachytherapy
lokal Aged, 80 and over [MeSH]
lokal Aged [MeSH]
lokal Margins of Excision [MeSH]
lokal Perioperative Period [MeSH]
lokal Radiation therapy
lokal Tongue Neoplasms/radiotherapy [MeSH]
lokal Feasibility Studies [MeSH]
lokal Neoplasm Staging [MeSH]
lokal Brachytherapy/adverse effects [MeSH]
lokal Survival
lokal Tongue Neoplasms/pathology [MeSH]
lokal Male [MeSH]
lokal Carcinoma, Squamous Cell/surgery [MeSH]
lokal Neck Dissection [MeSH]
lokal Tongue Neoplasms/surgery [MeSH]
lokal Neck dissection
lokal Carcinoma, Squamous Cell/pathology [MeSH]
lokal Original Research Article
lokal Combined Modality Therapy [MeSH]
lokal Oral cavity
lokal Tongue cancer
lokal Carcinoma, Squamous Cell/radiotherapy [MeSH]
lokal Female [MeSH]
lokal Adult [MeSH]
lokal Kaplan-Meier Estimate [MeSH]
lokal Humans [MeSH]
lokal Prospective Studies [MeSH]
lokal Middle Aged [MeSH]
lokal Squamous cell carcinoma
lokal Tongue Neoplasms/mortality [MeSH]
lokal Oral cancer
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/SWFub3Zza2ksIElsaWE=|https://frl.publisso.de/adhoc/uri/TWx5bmFyZWssIEFsZXggTS4=|https://frl.publisso.de/adhoc/uri/QmxhY2ssIE1hcnRpbiBKLg==|https://frl.publisso.de/adhoc/uri/QmFob3JpYywgQm9yaXM=|https://frl.publisso.de/adhoc/uri/U3VsdGFuZW0sIEtoYWxpbA==|https://orcid.org/0000-0002-1888-9763
1000 Hinweis
  • DeepGreen-ID: d23a1d96e8c147cc888c5309980702db ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6477686.rdf
1000 Erstellt am 2024-05-21T10:12:38.776+0200
1000 Erstellt von 322
1000 beschreibt frl:6477686
1000 Zuletzt bearbeitet Wed May 22 08:50:21 CEST 2024
1000 Objekt bearb. Wed May 22 08:50:21 CEST 2024
1000 Vgl. frl:6477686
1000 Oai Id
  1. oai:frl.publisso.de:frl:6477686 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source